
Getinge
212,1
SEK
-0,09 %
GETI B
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Mindre end 1K følgere
-0,09%
+10,07%
+16,83%
+17,51%
+3,87%
+3,31%
-41,18%
+23,03%
+2.578,6%
Getinge is a global medical technology company that specializes in providing equipment and IT systems to the healthcare and life science industry. The company offers, among other things, solutions for operating theatres, intensive care units, sterilization centers and drug development. The company was founded in 1904 and has its headquarters in Gothenburg.
Læs mereMarkedsværdi
57,77 mia. SEK
Aktieomsætning
179,18 mio. SEK
Omsætning
34,76 mia.
EBIT %
8,21 %
P/E
35,29
Udbytteafkast, %
2,17 %
Finanskalender
22.4
2025
Generalforsamling '25
22.4
2025
Delårsrapport Q1'25
23.4
2025
Årligt udbytte
ViserAlle indholdstyper

Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins
Modular Finance IR Consensus: Getinge – Consensus estimates Q4 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Getinge invites fund managers, analysts, and media to Year-End Report 2024 conference call
Changes of the Nomination Committee of Getinge
Alexandra Holland appointed as EVP Communications at Getinge

Getinge AB, Audiocast with teleconference, Q3'24
Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings
Modular Finance IR Consensus: Getinge – Consensus estimates Q3 2024
Getinge invites fund managers, analysts, and media to Q3 Report 2024 conference call
Getinge's CE certificate for ECLS consumables reinstated
Getinge completes the acquisition of Paragonix Technologies
Getinge makes a provision of MBRL 240 related to Brazilian investigation
Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market

Getinge AB, Audiocast with teleconference, Q2'24
Getinge Interim Report April-June 2024: Higher sales, stronger margins and product launches with significant added value for customers
Modular Finance IR Consensus: Getinge – Consensus estimates Q2 2024
Getinge invites fund managers, analysts, and media to Q2 Report 2024 conference call
